Featured

Allergies

Telling Time by Asthma, Allergy Symptom Severity

Telling Time by Asthma, Allergy Symptom Severity

Clinicians are gaining a better understanding of how asthma and allergies are regulated by the circadian clock, which will help patients better alleviate their symptoms.

Latest Features

Telling Time by Asthma, Allergy Symptom Severity

Telling Time by Asthma, Allergy Symptom Severity

Clinicians are gaining a better understanding of how asthma and allergies are regulated by the circadian clock, which will help patients better alleviate their symptoms.

Addressing Smoking Cessation in Asthma

Addressing Smoking Cessation in Asthma

Smoking cessation in patients with asthma is associated with reduced symptoms, improved lung function and quality of life, reduced use of rescue medications, improved airway hyperresponsiveness, and decreased hyperactivity.

Budesonide/Formoterol for the Prevention of Serious Asthma Exacerbations

Budesonide/Formoterol for the Prevention of Serious Asthma Exacerbations

The SYGMA trials assessed the use of an as-needed combined corticosteroid/beta-agonist inhaler in patients with mild asthma.

Illicit Drug Use in Asthma: Heroin, Cocaine, and Marijuana Worsen Symptoms

Illicit Drug Use in Asthma: Heroin, Cocaine, and Marijuana Worsen Symptoms

Inhaling and smoking heroin and cocaine increase the risk for asthma exacerbations and decreased pulmonary function; marijuana is associated with wheezing, cough, and sputum production.

COPD, Asthma, or Asthma COPD Overlap Syndrome: Diagnostic Challenges

COPD, Asthma, or Asthma COPD Overlap Syndrome: Diagnostic Challenges

Emerging guidelines for diagnosing and treating asthma COPD overlap syndrome will help clinicians better manage patients and prevent serious adverse effects.

Breathing New Life Into COPD and Asthma Therapy With Statins

Breathing New Life Into COPD and Asthma Therapy With Statins

Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.

Prevent Treatment Nonadherence in Asthma, COPD: Build Strong Patient Relationships

Prevent Treatment Nonadherence in Asthma, COPD: Build Strong Patient Relationships

Patients with asthma or chronic obstructive pulmonary disease have especially high rates of nonadherence, even in comparison with other chronic diseases.

Asthma Development in Early Childhood May Hinge on Early Life Stress

Asthma Development in Early Childhood May Hinge on Early Life Stress

Prenatal and early life stress, including societal stress, have been implicated in the development of asthma and other allergic diseases in children.

Volatile Organic Compound Analysis in Pediatric Asthma: A New Clinical Tool

Volatile Organic Compound Analysis in Pediatric Asthma: A New Clinical Tool

Analyzing volatile organic compounds in pediatric patients with asthma shows promise for disease diagnosis and management.

Precision Medicine May Pave the Way for Better Treatment in Asthma, COPD

Precision Medicine May Pave the Way for Better Treatment in Asthma, COPD

At a research seminar held by the European Respiratory Society in February 2017, a group of investigators discussed how precision medicine may improve treatment in asthma and COPD.

Latest

Oral Corticosteroid Use in Asthma May Increase Risk for Complications

Oral Corticosteroid Use in Asthma May Increase Risk for Complications

The study authors aimed to assess AE risk and complications of OCS use in patients with asthma since most studies only report them in non-asthmatic patients.

Antibody Response to Flu Vaccine Evaluated in Benralizumab-Treated Asthma

Antibody Response to Flu Vaccine Evaluated in Benralizumab-Treated Asthma

The trial analyzed the antibody response of 103 asthmatic patients to the seasonal influenza vaccine.

PM2.5 Exposure Linked to Asthma Rescue Medication Use

PM2.5 Exposure Linked to Asthma Rescue Medication Use

A 12% decrease in PM2.5 concentrations would result in an economic benefit of nearly $350 million annually.

Lower Maternal Vitamin D and E Intake Linked to Higher Childhood Asthma Risk

Lower Maternal Vitamin D and E Intake Linked to Higher Childhood Asthma Risk

The risk for asthma and wheezing in the first 10 years of childhood have been linked to a low maternal intake of vitamins D and E.

Omalizumab Shows Promise as Rescue Therapy in Status Asthmaticus

Omalizumab Shows Promise as Rescue Therapy in Status Asthmaticus

Omalizumab rescue therapy produced rapid results in a patient with refractory status asthmaticus.

Fatty Fish and Mediterranean Diet Effective as Asthma Treatment in Children

Fatty Fish and Mediterranean Diet Effective as Asthma Treatment in Children

A Mediterranean diet, including 2 servings of fatty fish per week, has the potential to reduce airway inflammation in children with asthma.

Mepolizumab Considered Safe, Effective for Severe Eosinophilic Asthma

Mepolizumab Considered Safe, Effective for Severe Eosinophilic Asthma

Mepolizumab demonstrated long-term safety and efficacy in the management of severe eosinophilic asthma.

Telling Time by Asthma, Allergy Symptom Severity

Telling Time by Asthma, Allergy Symptom Severity

Clinicians are gaining a better understanding of how asthma and allergies are regulated by the circadian clock, which will help patients better alleviate their symptoms.

Overweight, Obesity in Childhood Linked to Increased Asthma Risk

Overweight, Obesity in Childhood Linked to Increased Asthma Risk

In the absence of overweight and obesity, 10% of all pediatric asthma cases would be avoided.

Childhood Asthma, Wheezing Linked to Maternal Blood Pressure in Pregnancy

Childhood Asthma, Wheezing Linked to Maternal Blood Pressure in Pregnancy

Consistent associations were observed per 5 mm Hg higher maternal blood pressures in early pregnancy with lower FEV1/FVC.

Insurance Gaps May Increase Emergency Department Visits in Children With Asthma

Insurance Gaps May Increase Emergency Department Visits in Children With Asthma

Gaps in insurance coverage increased the odds of asthma-related emergency department intervention or hospitalization and exacerbations.

Symptom Free Days Questionnaire Lacks Reliability in Black Asthma Patients

Symptom Free Days Questionnaire Lacks Reliability in Black Asthma Patients

The Symptom Free Days Questionnaire may not be a reliable measurement in black patients with asthma.

Elevated Urinary 3-Bromotyrosine Alone Does Not Enhance Prediction of AERD

Elevated Urinary 3-Bromotyrosine Alone Does Not Enhance Prediction of AERD

Urinary 3-bromotyrosine levels cannot be used as a single parameter to diagnose aspirin-exacerbated respiratory disease.

Pediatric Asthma Hospital Stay and Caregiver Knowledge Linked

Pediatric Asthma Hospital Stay and Caregiver Knowledge Linked

Children of caregivers with poor asthma knowledge more likely to have prolonged hospital stay

Maximum Symptom Day Validated as Measure of Asthma Control

Maximum Symptom Day Validated as Measure of Asthma Control

The maximum symptom day has been confirmed as a reliable, responsive, and valid tool for measuring asthma symptom control.

Increased Medication Burden for Patients With Both Asthma and Allergies

Increased Medication Burden for Patients With Both Asthma and Allergies

Patients with both asthma and allergies had a significant increase in the number of prescriptions dispensed for controller medications.

Reslizumab Improves Sleep Quality in Inadequately Controlled Asthma

Reslizumab Improves Sleep Quality in Inadequately Controlled Asthma

Patients who received reslizumab experienced significantly greater improvements in each sleep-related related Asthma Quality of Life Questionnaire question score compared with placebo.

Lung Function in Persistent Asthma Improves With Inhaled Beclomethasone Dipropionate

Lung Function in Persistent Asthma Improves With Inhaled Beclomethasone Dipropionate

Significant improvements were seen in lung function in patients who received either dose of beclomethasone dipropionate.

Asthma Treatment Adherence: Once-Daily vs Twice-Daily Regimens

Asthma Treatment Adherence: Once-Daily vs Twice-Daily Regimens

The mean proportion of days covered in the fluticasone furoate/vilanterol group was significantly higher than in the budesonide/formoterol and fluticasone propionate/salmeterol groups.

Benralizumab Reduces Rescue Medication Use in Severe Eosinophilic Asthma

Benralizumab Reduces Rescue Medication Use in Severe Eosinophilic Asthma

By day 3, patients with severe eosinophilic asthma who received benralizumab required less use of rescue medication.

Sign Up for Free e-newsletters